NASDAQ: RPHM - Reneo Pharmaceuticals, Inc.

Lønnsomhet i seks måneder: +7.06%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Reneo Pharmaceuticals, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-04-08
ISIN US75974E1038
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://reneopharma.com
Цена ао 1.82
Prisendring per dag: 0% (1.82)
Prisendring per uke: 0% (1.82)
Prisendring per måned: 0% (1.82)
Prisendring over 3 måneder: 0% (1.82)
Prisendring over seks måneder: +7.06% (1.7)
Prisendring per år: +9.64% (1.66)
Prisendring over 3 år: -47.85% (3.49)
Prisendring siden begynnelsen av året: 0% (1.82)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 0.4847 10
P/E 0 0
EV/EBITDA -0.1973 0
Total: 3.75

Effektivitet

Navn Betydning Karakter
ROA, % -72.03 0
ROE, % -87.34 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0118 10
Total: 9.2

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 433.98 10
Lønnsomhet EPS, % 1476.7 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
NEA Management Company, LLC 4785494 14.32
Tang Capital Management, LLC 3330000 9.96
Carlyle Group Inc. 2698957 8.08
RiverVest Venture Management LLC 2534220 7.58
Octagon Capital Advisors LP 2250000 6.73
Bml Capital Management, LLC 1314229 3.93
Highbridge Capital Management, LLC. 1121704 3.36
Blackrock Inc. 983304 2.94
Vanguard Group Inc 978889 2.93
Aisling Capital Management LP 886075 2.65

ETFDele, %Lønnsomhet for året, %Utbytte, %
iShares Micro-Cap ETF 0.00768 17.09 1.54048
Principal Healthcare Innovators ETF 0.00594 618.5 0.8416
Future Tech ETF 0.00594 426.34 0.8416
Invesco Nasdaq Biotechnology ETF 0.00486 28.58 0.8565
ProShares Ultra Nasdaq Biotechnology 0.00333 51.7 0.85651
0.01228.440.99



Veileder Stillingstittel Betaling Fødselsår
Mr. Michael G. Grey Founder & Executive Chairman 100k 1953 (72 år)
Mr. Gregory J. Flesher President, CEO & Director 569.7k 1970 (55 år)
Mr. Michael P. Cruse Chief Operating Officer 535.47k 1972 (53 år)
Ms. Jennifer P. Lam SVP of Finance & Administration and Principal Financial & Accounting Officer N/A
Dr. Alejandro Dorenbaum M.D. Chief Medical Officer 466.23k 1961 (64 år)

Adresse: United States, Irvine. CA, 18575 Jamboree Road - åpne i Google maps, åpne Yandex-kart
Nettsted: https://reneopharma.com